Biogen’s Q4 EPS surges 52% to $3.79



Biogen Inc. shared on Tuesday that its GAAP diluted earnings per share (EPS) for the fourth quarter of fiscal 2022 amounted to $3.79, soaring approximately 52% year over year. In the reported period, …
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento